Patent · US Active

Liquid oral formulations for sildenafil

US11759468B2 · kind B2 · utility

0Cited by

1References

30Claims

0Family size

Assignee

Liqmeds Worldwide Limited · GB

Inventors

Jinal PANDYA · Shihi Village, IN
Sandip P. Mehta · Ahmedabad, IN
Manish Umrethia · Ahmedabad, IN
Jayanta Kumar MANDAL · Ahmedabad, IN
Hiren PANSURIYA · Ahmedabad, IN

Key dates

Filing date	Aug 31, 2022
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Aug 31, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.